| [1] | Welz M., van der Aalst C.M., Alfons A., et al. (2025). A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trials. Nat. Commun. 16:8060. DOI:10.1038/s41467-025-63471-6 |
| [2] | Wisnivesky J.P., Yung R.C., Mathur P.N., et al. (2013). Diagnosis and treatment of bronchial intraepithelial neoplasia and early lung cancer of the central airways: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e263S−e277S. DOI:10.1378/chest.12-2358 |
| [3] | Buma A.I.G., Muntinghe-Wagenaar M.B., Noort V.V.D., et al. (2025). Lung cancer detection by electronic nose analysis of exhaled breath: A multicentre prospective external validation study. Ann. Oncol. 36:786−795. DOI:10.1016/j.annonc.2025.03.013 |
| [4] | Chemi F., Pearce S.P., Clipson A., et al. (2022). cfDNA methylome profiling for detection and subtyping of small cell lung cancers. Nat. Cancer 3:1260−1270. DOI:10.1038/s43018-022-00415-9 |
| [5] | Panakkal N., Lekshmi A., Saraswathy V.V., et al. (2023). Effective lung cancer control: An unaccomplished challenge in cancer research. Cytojournal 20:16. DOI:10.25259/Cytojournal_36_2022 |
| Qian F., Zhang B., Tu H., et al. (2026). Is LDCT sufficient for screening central-type lung cancer? The Innovation Medicine 4:100250. https://doi.org/10.59717/j.xinn-med.2026.100250 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Ideal future screening strategy.